More Post from the Author
- Johnny Lieberman of Harbor IT named Entrepreneur Of The Year 2026 New York finalist by EY US
- LITO Announces New Collaboration Bringing Exclusive Contemporary Artist Editions to Sotheby's Online Marketplace
- SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
OUTFRONT Media Chief Financial Officer Matthew Siegel to Participate in the Morgan Stanley Technology, Media & Telecom Conference
NEW YORK, Feb. 26, 2025 /PRNewswire/ -- OUTFRONT Media Inc. (NYSE: OUT) announced today that Matthew Siegel, Executive Vice President and Chief Financial Officer, is scheduled to present at the Morgan Stanley Technology, Media & Telecom Conference on Monday, March 3, 2025 at 7:05 p.m. Eastern Time. A live and replay audio webcast will be available on the investor relations section of the Company's website atwww.outfront.com.
About OUTFRONT Media Inc.
OUTFRONT leverages the power of technology, location, and creativity to connect brands with consumers outside of their homes through one of the largest and most diverse sets of billboard, transit, and mobile assets in the United States. Through its technology platform, OUTFRONT will fundamentally change the ways advertisers engage audiences on-the-go.
Contacts: | ||
Investors | Media | |
Stephan Bisson | Courtney Richards | |
Investor Relations | Communications & Event Manager | |
(212) 297-6573 | (646) 876-9404 | |
SOURCE OUTFRONT Media Inc.

More Post from the Author
- Johnny Lieberman of Harbor IT named Entrepreneur Of The Year 2026 New York finalist by EY US
- LITO Announces New Collaboration Bringing Exclusive Contemporary Artist Editions to Sotheby's Online Marketplace
- SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
